SecBot SecBot
6-K ·Filed Nov 4, 2026

ATS

ATS Corp /ATS
BEARISH
Impact 6/10
Horizonweeks Processed12d 16h ago SEC0001394832-26-000028
6-K: Earnings release
Actionable Insight ▼ Bearish

Monitor Q3 FY2027 revenue against the $640M-$680M guidance range and watch for order booking recovery in non-life sciences as Section 338 tariff modifications take effect. The Fixed Cost Transformation Program's $65M-$75M annualized savings target is key to margin recovery, but lower volumes are temporarily offsetting benefits.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$17.57
T+0 close · Nov 4, 2026 · via day close
Latest settled
+0.46%
T+5 · $17.65
Vs SPY
+1.37%
α at T+5
Next horizon
T+20
in 16d
  1. T+0 · Nov 4 $17.57entry
  2. T+1 · 12d ago −1.42%α +2.99% · $17.32
  3. T+5 · 6d ago +0.46%α +1.37% · $17.65
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

ATS reported Q2 FY2027 revenue of $665.8M, down 8.6% YoY, and a net loss of $5.0M vs net income of $33.6M a year ago. Management withdrew its prior guidance for modest revenue growth and 50-75 bps margin expansion in FY2027, citing temporary delays in non-life sciences bookings from tariff uncertainty, and guided Q3 FY2027 revenue of $640M-$680M. Order bookings rose 12.7% YoY to $827M, led by life sciences, but adjusted EBITDA margin contracted 211 bps to 12.1%.

Key Financial Metrics

EPS (Adj.)
$0.27
est $0.23 · +17.4% · GAAP: $-0.05
Revenue
$665.8M
est $679.9M · -2.1% · -8.6% YoY
Rating
in line
Guidance
$640M-$680M
lowered
Free Cash Flow
$36.5M
Gross Margin
28.5%

Key Facts

  • Q2 FY2027 revenue $665.8M, down 8.6% YoY from $728.5M
  • Net loss of $5.0M vs net income of $33.6M a year ago
  • Adjusted basic EPS $0.27 vs $0.45 a year ago, down 40%
  • Management withdrew FY2027 guidance for modest revenue growth and 50-75 bps margin expansion
  • Q3 FY2027 revenue guidance of $640M-$680M
  • Order bookings $827M, up 12.7% YoY; life sciences bookings at second-highest quarter on record
  • Order backlog $2,009M, down 2.9% YoY
  • Adjusted EBITDA margin 12.1% vs 14.2% a year ago, down 211 bps
  • Restructuring costs of $21.3M in Q2, half related to Fixed Cost Transformation Program
  • Section 338 tariffs caused customer delays in packaging automation equipment; modifications announced late October expected to reduce impact
  • Net debt to pro forma adjusted EBITDA at 3.1x, above the 2.0-3.0x target range
  • Company repurchased 2,244,461 shares for $61.3M under NCIB during the quarter
  • Disclosure controls and procedures not effective due to a material weakness in ICFR

Financial Impact

Revenue decline of $62.7M YoY (8.6%), net loss swing of $38.6M, adjusted EBITDA down $23.0M (22.2%)

revenuenet incomeadjusted EBITDAadjusted EPSmargins

Segment Breakdown

SegmentRevenueGrowth
Life Sciences$355.8M-5.0%
Industrial Consumer$136.4M-23.5%
Food Beverage$99.6M-20.2%
Energy$74.0M+45.1%

Risk Factors

  • Continued tariff uncertainty and customer capital expenditure delays could further pressure revenue and margins
  • Net debt leverage at 3.1x above target range limits financial flexibility
  • Material weakness in internal controls over financial reporting remains unremediated
  • Restructuring execution risk and potential for additional workforce reductions
  • Lower GLP-1-related activity and portfolio repositioning in industrial consumer may persist

Market Snapshot

Exchange
NYSE
Sector
General Industrial Machinery & Equipment, NEC
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 10 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001394832-26-000028
Document: ats-financialstatementsxfy.htm0001394832-26-000028
Document: ats-pressreleasexfy27q2.htm0001394832-26-000028
Document: form6k-fy27q2.htm0001394832-26-000028
Document: q2fy27-atsceocertification.htm0001394832-26-000028
Document: q2fy27-atscfocertification.htm0001394832-26-000028
Document: 0001394832-26-000028-index-headers.html0001394832-26-000028
Document: 0001394832-26-000028-index.html0001394832-26-000028
Document: 0001394832-26-000028.txt0001394832-26-000028
Earnings Context (Synthetic; results releases only)0001394832-26-000028

Track record

13 reports on ATS

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $16.97 to $17.50 Now $17.96 +5.83% ▲ +3.12% +0.53% vs SPY
  2. Nov 4, 202612d ago 6-K Bearish 6/10 Viewing Entry $17.57 to $17.65 Now $17.96 −2.22% ▼ −0.46% −1.37% vs SPY
  3. Oct 30, 202617d ago 6-K Neutral 2/10 Entry $18.97 to $17.74 Now $17.96 −5.32% ▼ −6.48% −6.56% vs SPY
  4. Sep 3, 202610w ago 6-K Neutral 2/10 Entry $19.57 to $19.20 Now $17.96 −8.23% ▼ −1.89% −0.74% vs SPY
  5. Aug 9, 202614w ago Institutional Cluster Bearish 5/10 Entry $19.73 to $19.59 Now $17.96 +8.97% ▲ +0.71% +0.66% vs SPY
  6. Aug 7, 202614w ago 6-K Neutral 2/10 Entry $21.13 to $20.31 Now $17.96 −15.00% ▼ −3.88% −4.28% vs SPY
  7. Aug 6, 202614w ago 6-K Bearish 7/10 Entry $20.53 to $20.13 Now $17.96 +12.52% ▲ +1.95% +3.16% vs SPY
  8. Jul 27, 202616w ago 6-K Neutral 2/10 Entry $26.59 to $27.24 Now $17.96 −32.46% ▲ +2.44% +1.37% vs SPY
  9. Jul 2, 202619w ago 6-K Neutral 2/10 Entry $27.68 to $27.74 Now $17.96 −35.12% ▲ +0.22% −0.71% vs SPY
  10. Jun 11, 202622w ago 6-K Neutral 2/10 Entry $26.88 to $28.32 Now $17.96 −33.18% ▲ +5.36% +4.92% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens Wed (10h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026